Y-mAbs Therapeutics, Inc.: Please contact the Portnoy Law Firm to recover your losses; March 20, 2023 deadline
March 17, 2023 16:19 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 17, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Y-mAbs Therapeutics, Inc....
Y-mAbs Therapeutics, Inc.: Please contact the Portnoy Law Firm to recover your losses; March 20, 2023 deadline
March 10, 2023 12:00 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 10, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Y-mAbs Therapeutics, Inc....
Y-mAbs Therapeutics, Inc. (YMAB) Class Action Notice: Robbins LLP Urges Shareholders to Contact the Firm for Information Regarding Their Rights
March 08, 2023 11:57 ET
|
Robbins LLP
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased shares of Y-mAbs...
Y-mAbs Therapeutics, Inc.: Please contact the Portnoy Law Firm to recover your losses; March 20, 2023 deadline
February 16, 2023 19:06 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Y-mAbs Therapeutics, Inc....
Y-mAbs Therapeutics, Inc. (YMAB) Class Action Notice: Robbins LLP Urges Shareholders to Contact the Firm for Information Regarding Their Rights
February 09, 2023 15:04 ET
|
Robbins LLP
SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased shares of Y-mAbs...
Y-mAbs Therapeutics, Inc. (YMAB) Investor Alert: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in Class Action Against Y-mAbs Therapeutics, Inc.
February 02, 2023 15:23 ET
|
Robbins LLP
SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased shares of Y-mAbs...
Y-mAbs Therapeutics, Inc. (YMAB) Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Y-mAbs Therapeutics, Inc.
January 24, 2023 14:31 ET
|
Robbins LLP
SAN DIEGO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased shares of Y-mAbs...
Y-mAbs Therapeutics, Inc.: Please contact the Portnoy Law Firm to recover your losses; March 20, 2023 deadline
January 22, 2023 17:39 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 22, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Y-mAbs Therapeutics, Inc....
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) Investor Alert: Kaplan Fox & Kilsheimer LLP Notifies Y-mAbs Investors of a Class Action Lawsuit and Upcoming Lead Plaintiff Deadline
January 19, 2023 18:24 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigation of claims on behalf of investors in Y-mAbs Therapeutics, Inc....
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) Investor Update: Kaplan Fox Continues to Investigate Potential Securities Fraud
December 02, 2022 13:10 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigation of claims on behalf of investors in Y-mAbs Therapeutics, Inc....